SHANGHAI HUAYI BIO LAB CO LTD has a total of 21 patent applications. Its first patent ever was published in 2001. It filed its patents most often in China, Canada and Republic of Korea. Its main competitors in its focus markets pharmaceuticals, biotechnology and environmental technology are KALEYDE PHARMACEUTICALS AG, WITHYOU BIOTECHNOLOGY CO LTD and NELSON PETER JON.
# | Country | Total Patents | |
---|---|---|---|
#1 | China | 10 | |
#2 | Canada | 2 | |
#3 | Republic of Korea | 2 | |
#4 | United States | 2 | |
#5 | WIPO (World Intellectual Property Organization) | 2 | |
#6 | Brazil | 1 | |
#7 | EPO (European Patent Office) | 1 | |
#8 | Japan | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Peptides | |
#3 | Medical preparations | |
#4 | Climate change mitigation in goods production |
# | Name | Total Patents |
---|---|---|
#1 | Yu Gang | 7 |
#2 | Zuo Yajun | 6 |
#3 | Yue Peng | 5 |
#4 | Bao Wenchao | 4 |
#5 | Xu Hongjing | 4 |
#6 | Zhu Zhiyong | 3 |
#7 | Wu Dengxi | 3 |
#8 | Sun Yukun | 3 |
#9 | He Yunxia | 2 |
#10 | Xiong Chunlin | 2 |
Publication | Filing date | Title |
---|---|---|
CN103405753A | Stable exendin water injection medicine composition | |
CN102816785A | Preparation method of insulin glargine and analogue thereof | |
CN102604149A | Three-dimensional chitosan hydrogel and preparation method thereof | |
CN102718868A | Fixed point mono-substituted pegylation of Exendin analogue and preparation method thereof | |
CN101798588A | Method for testing bioactivities of GLP-1 receptor agonist | |
CN102827284A | Exendin or analogue containing polyethylene glycol group and preparation and application thereof | |
CN101643504A | Exendin 4 analogue | |
CN1732903A | Method for preparing sustained-release microsphere | |
CN1363559A | Insulinotropic hormone secretion peptide derivative |